| No | N+ | ||||
---|---|---|---|---|---|---|
 | HER-2 | HER-2 | ||||
 | Negative | Positive | Total | Negative | Positive | Total |
ER- PR- | 27(90%) | 3 (10%) | 30 | 7 (35%) | 13 (65%) | 20 |
ER- PR+ | 7 (100%) | 0 (0%) | 7 | 1 (16.7%) | 5 (83.3%) | 6 |
ER+ PR- | 14 (100%) | 0(0%) | 14 | 7 (77.8%) | 2 (22.2%) | 9 |
ER+ PR+ | 38 (97,4%) | 1(2.6%) | 39 | 25 (86,2%) | 4 (13,8%) | 29 |
Total | 86 (95.55) | 4(3.45) | 90 | 40 (62.5) | 24 (37.5) | 64 |